BIOMAT Database Logo BIOMAT Database Logo

YAC and cosmid contigs encompassing the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region on 9q31. 1997

M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Department of Human Genetics, Graduate School of International Health, University of Tokyo, Japan.

Fukuyama-type congenital muscular dystrophy (FCMD), the second most common form of childhood muscular dystrophy in Japan, is an autosomal recessive severe muscular dystrophy associated with an anomaly of the brain. We had mapped the FCMD gene to an approximately 5-cM interval between D9S127 and D9S2111 on 9q31-q33 and had also found evidence for linkage disequilibrium between FCMD and D9S306 in this candidate region. Through further analysis, we have defined another marker, D9S172, which showed stronger linkage disequilibrium than D9S306. A yeast artificial chromosome (YAC) contig spanning 3,5 Mb, which includes this D9S306-D9S172 interval on 9q31, has been constructed by a combination of sequence-tagged site, Alu-PCR, and restriction mapping. Also, cosmid clones subcloned from the YAC were assembled into three contigs, one of which contains D9S2107, which showed the strongest linkage disequilibrium with FCMD. These contigs also allowed us to order the markers as follows: cen-D9S127-(approximately 800 kb)-D9S306 (identical to D9S53)-(approximately 700 kb)-A107XF9-(approximately 500 kb)-D9S172-(approximately 30 kb)-D9S299 (identical to D9S774)-(approximately 120 kb)-WI2269-tel. Thus, we have constructed the first high-resolution physical map of the FCMD candidate region. The YAC and cosmid contigs established here will be a crucial resource for identification of the FCMD gene and other genes in this region.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002899 Chromosomes, Human, Pair 9 A specific pair of GROUP C CHROMSOMES of the human chromosome classification. Chromosome 9
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003360 Cosmids Plasmids containing at least one cos (cohesive-end site) of PHAGE LAMBDA. They are used as cloning vehicles. Cosmid
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome

Related Publications

M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
June 2003, Congenital anomalies,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Restriction map of a YAC and cosmid contig encompassing the oculopharyngeal muscular dystrophy candidate region on chromosome 14q11.2-q13.
September 1998, Genomics,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
[Molecular genetics and merosin abnormality in Fukuyama-type congenital muscular dystrophy (FCMD)].
December 1997, Nihon rinsho. Japanese journal of clinical medicine,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Polymorphism analysis of Fukuyama type congenital muscular dystrophy (FCMD) siblings with different phenotypes.
April 1997, Brain & development,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
[Fukuyama type congenital muscular dystrophy (FCMD) with a long survival--an autopsy case report].
June 1987, Rinsho shinkeigaku = Clinical neurology,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
[Is Walker-Warburg syndrome a severe variant of Fukuyama type congenital muscular dystrophy (FCMD)?].
May 1985, No to hattatsu = Brain and development,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.
November 1993, Nature genetics,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Fukuyama-type congenital muscular dystrophy.
October 1982, The Journal of pediatrics,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
Fukuyama-type congenital muscular dystrophy.
October 1982, Archives of neurology,
M Miyake, and Y Nakahori, and I Matsushita, and K Kobayashi, and K Mizuno, and M Hirai, and I Kanazawa, and Y Nakagome, and K Tokunaga, and T Toda
[Fukuyama type congenital muscular dystrophy].
January 2002, Revista de neurologia,
Copied contents to your clipboard!